Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$10.23 - $19.34 $305,877 - $578,266
-29,900 Closed
0 $0
Q4 2022

Feb 14, 2023

BUY
$5.01 - $11.83 $501,000 - $1.18 Million
100,000 Added 334.45%
129,900 $1.54 Million
Q3 2022

May 15, 2023

SELL
$4.57 - $8.4 $457,000 - $840,000
-100,000 Reduced 76.98%
29,900 $177,000
Q2 2022

Aug 15, 2022

SELL
$3.74 - $10.66 $95,370 - $271,830
-25,500 Reduced 46.03%
29,900 $127,000
Q1 2022

May 16, 2022

SELL
$7.81 - $20.45 $216,337 - $566,465
-27,700 Reduced 33.33%
55,400 $527,000
Q4 2021

Feb 15, 2022

BUY
$15.2 - $35.51 $314,640 - $735,057
20,700 Added 33.17%
83,100 $1.58 Million
Q3 2021

Nov 15, 2021

BUY
$21.78 - $40.45 $490,050 - $910,125
22,500 Added 56.39%
62,400 $2.08 Million
Q2 2021

Aug 16, 2021

BUY
$32.5 - $48.96 $971,750 - $1.46 Million
29,900 Added 299.0%
39,900 $1.55 Million
Q1 2021

May 17, 2021

SELL
$41.61 - $54.3 $6.2 Million - $8.09 Million
-149,000 Reduced 93.71%
10,000 $482,000
Q4 2020

Feb 16, 2021

BUY
$25.27 - $54.9 $3.77 Million - $8.18 Million
149,000 Added 1490.0%
159,000 $8.27 Million
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $89,000 - $218,400
10,000 New
10,000 $195,000
Q3 2019

Nov 13, 2019

SELL
$5.38 - $8.99 $615,472 - $1.03 Million
-114,400 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$6.27 - $8.65 $717,288 - $989,560
114,400 New
114,400 $990,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.2B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.